PAUL DAVID OLIVO, M.D.
Osteopathic Medicine at Polo Dr, Saint Louis, MO
License number
Missouri R8J70
Category
Osteopathic Medicine
Type
Internal Medicine
Address
Address
639 W Polo Dr, Saint Louis, MO 63105
Phone
(314) 640-9732
Personal information
See more information about PAUL DAVID OLIVO at radaris.comName
Address
Phone
639 Polo Dr, Saint Louis, MO 63105
7310 Kingsbury Ave, Saint Louis, MO 63130
Professional information
Vp At Dhi
Position:
VP at DHI
Location:
Greater St. Louis Area
Industry:
Medical Devices
Work:
DHI
-
VP
Paul David Olivo, Saint Louis MO
Specialties:
Internal Medicine, Critical Care Medicine, Infectious Disease
Work:
Washington University at St. Louis
660 S Euclid Ave, Saint Louis, MO 63110
660 S Euclid Ave, Saint Louis, MO 63110
Education:
University of Florida (1981)
Dr. Paul D Olivo, Saint Louis MO - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
WASHINGTON UNIVERSITY
660 S Euclid Ave SUITE 8230, Saint Louis 63110
(314) 362-5718 (Phone)
660 S Euclid Ave SUITE 8230, Saint Louis 63110
(314) 362-5718 (Phone)
Certifications:
Internal Medicine, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
University of Florida
Graduated: 1981
University Of Wisconsin-Madison
National Institutes Of Health Clinical Center
University of Florida
Graduated: 1981
University Of Wisconsin-Madison
National Institutes Of Health Clinical Center
Method Of Discovery And Development Of Broad-Spectrum Antiviral Drugs
US Patent:
2005016, Jul 28, 2005
Filed:
Jan 28, 2004
Appl. No.:
10/766226
Inventors:
Benjamin Buscher - St. Louis MO, US
Julie Dyall - St. Louis MO, US
Andrew O'Guin - St. Louis MO, US
Paul Olivo - Clayton MO, US
Robert Roth - St. Louis MO, US
Yi Zhou - Ballwin MO, US
Julie Dyall - St. Louis MO, US
Andrew O'Guin - St. Louis MO, US
Paul Olivo - Clayton MO, US
Robert Roth - St. Louis MO, US
Yi Zhou - Ballwin MO, US
International Classification:
C12Q001/70, C12Q001/68
US Classification:
435005000, 435006000
Abstract:
Method for identifying a broad-spectrum antiviral lead compound. Also methods for marketing and delivering a broad-spectrum antiviral compound and methods for treating patients with antiviral infections with a broad-spectrum antiviral drug are disclosed.
4-Aminoquinoline Compounds For Treating Virus-Related Conditions
US Patent:
2009022, Sep 3, 2009
Filed:
May 4, 2006
Appl. No.:
11/913530
Inventors:
Paul D. Olivo - Clayton MO, US
Benjamin A. Buscher - Madison WI, US
Julie Dyall - Bethesda MD, US
Andrew K. O'Guin - Waterloo IL, US
Robert M. Roth - St. Louis MO, US
Yi Zhou - Lexington MA, US
Gary W. Franklin - Godfrey IL, US
Gale W. Starkey - Richmond Heights MO, US
Benjamin A. Buscher - Madison WI, US
Julie Dyall - Bethesda MD, US
Andrew K. O'Guin - Waterloo IL, US
Robert M. Roth - St. Louis MO, US
Yi Zhou - Lexington MA, US
Gary W. Franklin - Godfrey IL, US
Gale W. Starkey - Richmond Heights MO, US
International Classification:
A61K 31/435, A61K 31/47, A61P 31/12
US Classification:
514290, 514313
Abstract:
This invention is directed to aminoquinoline compounds, pharmaceutical compositions of such compounds, kits comprising such compounds, and uses of such compounds for preparing medicaments and treating virus-related conditions in animals.
Compounds, Compositions, And Methods For Control Of Hepatitis C Viral Infections
US Patent:
2011026, Oct 27, 2011
Filed:
Oct 29, 2009
Appl. No.:
13/126619
Inventors:
Urszula Slomczynska - Ballwin MO, US
Paul Olivo - Clayton MO, US
Jodi Beattie - Wentzville MO, US
Gale Starkey - St.Llouis MO, US
Amine Noueiry - St. Louis MO, US
Robert Roth - St. Louis MO, US
Paul Olivo - Clayton MO, US
Jodi Beattie - Wentzville MO, US
Gale Starkey - St.Llouis MO, US
Amine Noueiry - St. Louis MO, US
Robert Roth - St. Louis MO, US
Assignee:
APATH, LLC - Brooklyn NY
International Classification:
A61K 38/21, A61K 31/519, A61K 31/7056, A61P 31/14, A61K 31/7088, A61K 39/395, C07H 21/00, C12Q 1/70, C07D 487/04, A61K 31/713
US Classification:
424 854, 544281, 5142593, 514 43, 514 44 A, 4241301, 536 2372, 435 5
Abstract:
Various tetrahydropyrazolo[1,5-a]pyrimidine compounds, compositions, methods of making, and methods for the prevention and treatment of HCV infections and associated diseases are disclosed. The invention further relates to biomarkers for identification of HCV strains which are resistant to the tetrahydropyrazolo[1,5-a]pyrimidine compounds.